ASND smart money

Ascendis Pharma A/S (ASND): 2 insider buys, 12 top funds holding it, 9 ETF changes in the public filings.

Insider buys, 12 months$548k

Insider buys

FiledWhoRoleAmountPrice
2026-08-18Bienaime Jean JacquesDirector$493k$245.85
2026-06-01Smith Scott ThomasEVP & Chief Financial Officer$56k$223.32

Top 100 funds holding it

#FundChangeWeightValue
24Orbimed Advisors LLCADD +41%1.45%$79M
38Ars Investment Partners, LLC2.11%$47M
50Siren, L.L.C.BUY0.70%$30M
51Dafna Capital Management LLCADD +3%2.43%$11M
53Eagle Health Investments LPADD +12%4.65%$27M
63Vestal Point Capital, LPADD +97%4.36%$169M
74First Turn Management, LLCTRIM -48%1.65%$12M
76Polar Capital Holdings PLCADD +5%0.41%$147M
80Avoro Capital Advisors LLC11.87%$1.2B
83Tri Locum Partners LPTRIM -54%5.33%$27M
86Adar1 Capital Management, LLC0.30%$6M
96Pfm Health Sciences, LP5.57%$52M

ETF changes

ETFChangeValueReport
T. Rowe Price Capital Appreciation Equity ETFBUY+$93M2026-06-30
T. Rowe Price Capital Appreciation Equity ETFSELL−$76M2026-06-30
Sapient Quality Select ETFADD+$29M2026-07-31
American Century Focused Dynamic Growth ETFBUY+$10M2026-05-31
American Century Focused Dynamic Growth ETFTRIM−$10M2026-05-31
Ishares U.S. Healthcare ETFBUY+$7M2026-07-31
Invesco Nasdaq Next Gen 100 ETFBUY+$7M2026-05-31
Invesco Nasdaq Next Gen 100 ETFSELL−$6M2026-05-31
Franklin Focused Dynamic Growth ETFSELL−$2M2026-06-30
Open the live smart money map